![John Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Evans
Algemeen Directeur bij
BEAM THERAPEUTICS INC.
Vermogen: 38 M $ op 31-05-2026
Profiel
Momenteel bekleedt John Evans de functie van Chief Executive Officer & Director bij Beam Therapeutics, Inc. en Venture Partner bij ARCH Venture Partners LLC. De heer Evans zit ook in de raad van bestuur van Verve Therapeutics, Inc. Voordien was hij Vice President-Business Development & Operations bij Agios Pharmaceuticals, Inc. en Investor Relations Contact bij Infinity Pharmaceuticals, Inc. De heer Evans is afgestudeerd aan de Universiteit van Pennsylvania, heeft een doctoraatsdiploma van Yale University en een MBA van The Wharton School van de Universiteit van Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-04-2026 | 1.150.205 ( 1,12% ) | 38 M $ | 31-05-2026 |
Laatste nieuws over John Evans
Actieve functies van John Evans
| Bedrijven | Functie | Begin |
|---|---|---|
| BEAM THERAPEUTICS INC. | Algemeen Directeur | 01-01-2017 |
Blink Therapeutics, Inc.
 Blink Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platform to generate therapeutic and diagnostic monoclonal antibodies | Algemeen Directeur | - |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Directeur/Bestuurslid | - |
Eerdere bekende functies van John Evans
| Bedrijven | Functie | Einde |
|---|---|---|
| PRIME MEDICINE, INC. | Directeur/Bestuurslid | 13-09-2022 |
| VERE THER | Directeur/Bestuurslid | 04-08-2022 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 31-03-2021 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-04-2017 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01-07-2006 |
Opleiding van John Evans
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
84
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Blink Therapeutics, Inc.
Blink Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platform to generate therapeutic and diagnostic monoclonal antibodies | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Health Technology |
